ABNX — Abionyx Pharma SA Cashflow Statement
0.000.00%
Last trade - 00:00
- €30.16m
- €32.53m
- €5.25m
2018 December 31st | 2019 December 31st | 2020 December 31st | 2021 December 31st | 2022 December 31st | |
---|---|---|---|---|---|
Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
Source: | ARS | ARS | ARS | ARS | ARS |
Standards: | IFRS | IFRS | IFRS | IFRS | IFRS |
Status: | Final | Final | Final | Final | Final |
Net Income/Starting Line | -6.3 | 1.85 | -1.89 | -5.82 | -4.21 |
Depreciation | |||||
Non-Cash Items | 1.25 | -4.86 | -0.865 | 0.755 | 0.615 |
Other Non-Cash Items | |||||
Changes in Working Capital | -0.981 | -0.954 | 2.13 | -1.74 | 0.097 |
Change in Prepaid Expenses | |||||
Change in Taxes Payable | |||||
Net Change in Other Assets & Liabilities | |||||
Cash from Operating Activities | -6 | -3.95 | -0.599 | -6.69 | -3.36 |
Capital Expenditures | -0.023 | 0 | -0.148 | -0.166 | -0.175 |
Purchase of Fixed Assets | |||||
Purchase / Acquisition of Intangibles | |||||
Other Investing Cash Flow Items | 0.013 | 0 | 0.023 | 1.5 | — |
Sale of Business | |||||
Sale of Fixed Assets | |||||
Change in Net Intangibles | |||||
Cash from Investing Activities | -0.01 | 0 | -0.125 | 1.34 | -0.175 |
Net Issuance / Retirement of Stock | |||||
Net Issuance / Retirement of Debt | |||||
Cash from Financing Activities | 1.2 | 0.823 | 1.55 | 3.97 | -0.194 |
Foreign Exchange Effects | |||||
Beginning Cash Balance | |||||
Ending Cash Balance | |||||
Net Change in Cash | -4.82 | -3.13 | 0.823 | -1.38 | -3.73 |